HUP2200147A1 - Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény - Google Patents

Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény

Info

Publication number
HUP2200147A1
HUP2200147A1 HU2200147A HUP2200147A HUP2200147A1 HU P2200147 A1 HUP2200147 A1 HU P2200147A1 HU 2200147 A HU2200147 A HU 2200147A HU P2200147 A HUP2200147 A HU P2200147A HU P2200147 A1 HUP2200147 A1 HU P2200147A1
Authority
HU
Hungary
Prior art keywords
palbociclib
letrozole
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HU2200147A
Other languages
English (en)
Inventor
Laszlo Ugrai
Lukacs Gyula Dr
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU2200147A priority Critical patent/HUP2200147A1/hu
Priority to US18/107,774 priority patent/US20230364093A1/en
Publication of HUP2200147A1 publication Critical patent/HUP2200147A1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU2200147A 2022-05-10 2022-05-10 Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény HUP2200147A1 (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU2200147A HUP2200147A1 (hu) 2022-05-10 2022-05-10 Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény
US18/107,774 US20230364093A1 (en) 2022-05-10 2023-02-09 Pharmaceutical composition containing palbociclib and letrozole

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU2200147A HUP2200147A1 (hu) 2022-05-10 2022-05-10 Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény
US17/891,566 US11672804B1 (en) 2022-08-19 2022-08-19 Pharmaceutical composition containing palbociclib and letrozole

Publications (1)

Publication Number Publication Date
HUP2200147A1 true HUP2200147A1 (hu) 2023-11-28

Family

ID=86701297

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2200147A HUP2200147A1 (hu) 2022-05-10 2022-05-10 Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény

Country Status (2)

Country Link
US (2) US11672804B1 (hu)
HU (1) HUP2200147A1 (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1470124T3 (da) * 2002-01-22 2006-04-18 Warner Lambert Co 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner

Also Published As

Publication number Publication date
US11672804B1 (en) 2023-06-13
US20230364093A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
EP4183391A4 (en) PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL311331A (en) Pharmaceutical preparation and its use
EP3828183A4 (en) SULFOXIMINE COMPOUND AS BROMO-DOMAIN INHIBITOR AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF
EP3858353A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NITM AND ASSOCIATED PHARMACEUTICAL USE
EP3753557A4 (en) PREVENTIVE OR THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES OR BONE DISEASES
EP4005591A4 (en) ANTINEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION
ZA202306105B (en) Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof
EP4023227A4 (en) PHARMACEUTICAL COMPOSITION AND ITS APPLICATION
EP4003332A4 (en) PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND ITS USE FOR PREVENTING AND/OR TREATING A DISEASE
EP4073071A4 (en) USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES
EP4103539A4 (en) COMPOUNDS AND PHARMACEUTICAL USES THEREOF
EP4095158A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING ANTI-BTLA ANTIBODIES AND USE THEREOF
FI4110292T3 (fi) Nestemäinen farmaseuttinen koostumus, joka käsittää ensifentriiniä ja glykopyrrolaattia
EP4062906A4 (en) ORAL PHARMACEUTICAL COMPOSITION COMPRISING A CARBAMATE COMPOUND AND METHOD FOR PREPARING THIS COMPOSITION
HUP2200147A1 (hu) Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény
EP4180040A4 (en) PHARMACEUTICAL COMPOSITION AND ITS APPLICATION
GB202217964D0 (en) Pharmaceutical and cosmetic compositions comprising secretomes
IL312238A (en) A pharmaceutical preparation and a kit containing an immunomodulatory agent for the treatment of diseases
EP4129283A4 (en) PHARMACEUTICAL COMBINATION AND USE THEREOF
KR102290295B9 (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
EP3995136A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN OR TAMSULOSIN HYDROCHLORIDE AND METHOD FOR THE PREPARATION THEREOF
AU2022397653A1 (en) Pharmaceutical composition and use thereof
NL2027551A (en) 1immunogenic polypeptides and pharmaceutical compositions
GB202403415D0 (en) Pharmaceutical composition
EP4100020A4 (en) PHARMACEUTICAL ASPACYTARABINE COMPOSITIONS AND USES THEREOF